35 — Far East Consortium International Balance Sheet
0.000.00%
- HK$2.69bn
- HK$27.19bn
- HK$10.20bn
- 26
- 93
- 35
- 52
Annual balance sheet for Far East Consortium International, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5,453 | 7,419 | 8,690 | 5,911 | 3,921 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,972 | 1,933 | 1,582 | 1,611 | 2,265 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 20,045 | 24,272 | 27,512 | 25,804 | 21,287 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 11,249 | 12,689 | 12,607 | 12,407 | 12,339 |
Net Goodwill | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 41,780 | 49,901 | 54,804 | 53,423 | 47,261 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8,933 | 15,715 | 15,215 | 24,914 | 16,152 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 27,757 | 33,220 | 37,271 | 38,164 | 32,678 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 14,023 | 16,681 | 17,533 | 15,259 | 14,583 |
Total Liabilities & Shareholders' Equity | 41,780 | 49,901 | 54,804 | 53,423 | 47,261 |
Total Common Shares Outstanding |